← Eichor
Condition: Prostate Cancer Patients Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Prostate Cancer Patients

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) for Response Monitoring to Neoadjuvant Abiraterone
Phase 2 · 1 location(s) · Ivan de Kouchkovsky, MD · NCT06384222A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
Phase 1/Phase 2 · 12 location(s) · Memorial Sloan Kettering Cancer Center · NCT06457919A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or M
Phase 1/Phase 2 · 4 location(s) · Genentech, Inc. · NCT07567846A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patien
Phase 2/Phase 3 · 2 location(s) · Shanghai Jiao Tong University School of Medicine · NCT03258320Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy in Black Men With Locally Advanced, Biochemically Recu
Phase 2 · 1 location(s) · Mayo Clinic · NCT07073794Feasibility of MR-Informed Adaptive Marker-less SBRT in Patients With Bilateral Hip Prostheses Undergoing SBRT for Local
NA · 1 location(s) · University of Zurich · NCT07042256Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Phase 2 · 18 location(s) · VA Office of Research and Development · NCT04038502Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer
Phase 2 · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT06330805CART-PSMA Cells for Advanced Prostate Cancer
Phase 1 · 1 location(s) · Nova Therapeutics LLC · NCT05656573Rezvilutamide in Patients With Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
Phase 2 · 2 location(s) · The Affiliated Nanjing Drum Tower Hospital of Nanjing Univer · NCT05753566The Added-value of PSMA PET in Detecting Clinically Significant Prostate Cancer Lesions in Patients Undergoing MRI-targe
NA · 1 location(s) · Jules Bordet Institute · NCT06867588Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05616650The CArdiovascular Risk Evaluation in Men With Prostate Cancer Study (CARE-PC) Pilot Feasibility Study
NA · 1 location(s) · Vivek Narayan · NCT06064149Study of 18F-Florastamin PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer
Phase 3 · 1 location(s) · HTA Co., Ltd. · NCT06754085LUtetium-177 DOsimetry as a Predictive Biomarker of Response in Metastatic Prostate Cancer Patients Treated With PSMA Ra
Phase N/A · 1 location(s) · Jules Bordet Institute · NCT07370597Evaluating Safety and Efficacy of Prostate-sparing Radical Cystectomy
NA · 2 location(s) · Johns Hopkins University · NCT05792722A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
Phase 1/Phase 2 · 15 location(s) · Phanes Therapeutics · NCT05652686Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate Cancer
Phase 1/Phase 2 · 1 location(s) · The Methodist Hospital Research Institute · NCT07182279National Robotics-Assisted Radical Prostatectomy Database
Phase N/A · 8 location(s) · Melbourne Health · NCT06279260In Vivo Dosimetry for Brachytherapy Study
Phase N/A · 1 location(s) · East and North Hertfordshire NHS Trust · NCT06863090A FIH, Phase I/IIa, Trial Assessing Feasibility of Administrations of TIL-based Immunotherapy in Patients With Metastati
Phase 1/Phase 2 · 1 location(s) · CuraCell TX AB · NCT07255664HS-10502 Combination Treatment in Patients With Advanced Solid Tumors
Phase 1 · 1 location(s) · Jiangsu Hansoh Pharmaceutical Co., Ltd. · NCT06769425Working Out M0 Bipolar Androgen Therapy
Phase 2 · 12 location(s) · Australian and New Zealand Urogenital and Prostate Cancer Tr · NCT06594926Fractionated Stereotactic Radiotherapy Plus Second-generation Antiandrogen for Oligometastatic Castration-resistant Pros
Phase 2 · 15 location(s) · Instituto de Investigación en Oncología Radioterápica - Fund · NCT07717268Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors
Phase 1 · 2 location(s) · Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd · NCT06666270Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy
Phase 3 · 1 location(s) · yair lotan · NCT02064673177Lu-P17-087/177Lu-P17-088 in Patients With Metastatic Castration-resistant Prostate Cancer
EARLY_Phase 1 · 1 location(s) · Peking Union Medical College Hospital · NCT05603559ASCVD Management Using CCTA in Prostate Cancer Patients on ADT
NA · 3 location(s) · Indiana University · NCT05879913PSMA PET for Surveillance After Focal Therapy
NA · 1 location(s) · University of Chicago · NCT0711591468Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients
EARLY_Phase 1 · 1 location(s) · Peking Union Medical College Hospital · NCT05549024
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.